KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Treasury Shares (2016 - 2025)

Abbott Laboratories' Treasury Shares history spans 17 years, with the latest figure at $17.2 billion for Q4 2025.

  • For Q4 2025, Treasury Shares rose 1.98% year-over-year to $17.2 billion; the TTM value through Dec 2025 reached $17.2 billion, up 1.98%, while the annual FY2025 figure was $17.2 billion, 1.98% up from the prior year.
  • Treasury Shares for Q4 2025 was $260.2 million at Abbott Laboratories, up from $257.9 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $260.2 million in Q4 2025 and bottomed at $2266.0 in Q3 2023.
  • The 5-year median for Treasury Shares is $249.4 million (2022), against an average of $230.6 million.
  • The largest annual shift saw Treasury Shares dropped 0.69% in 2021 before it surged 39.42% in 2022.
  • A 5-year view of Treasury Shares shows it stood at $11.8 billion in 2021, then rose by 28.82% to $15.2 billion in 2022, then rose by 4.94% to $16.0 billion in 2023, then rose by 5.4% to $16.8 billion in 2024, then rose by 1.98% to $17.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Treasury Shares are $17.2 billion (Q4 2025), $16.9 billion (Q3 2025), and $16.6 billion (Q2 2025).